<DOC>
	<DOCNO>NCT01296503</DOCNO>
	<brief_summary>This multicenter , prospective , randomized trial design evaluate role thalidomide without dexamethasone maintenance therapy multiple myeloma patient single autologous stem cell transplantation .</brief_summary>
	<brief_title>Thalidomide Plus Dexamethasone Maintenance Therapy Multiple Myeloma</brief_title>
	<detailed_description>Patients recruit prior receive induction therapy , randomization 1:1 ratio occur day 60 post-autologous stem cell transplantation . The treatment consist follow four phase : 1. induction 3-5 cycle vincristine plus doxorrubicin dexamethasone ( VAD ) every 21-28 day : vincristine 0.4 mg , doxorubicin 9 mg/m² oral dexamethasone 40 mg daily 4 day ; 2. cyclophosphamide ( 4 g/m2 ) plus filgrastim ( G-CSF ) ( 5 μg/kg twice day ) stem cell mobilization ; 3. melphalan ( 200 mg/m2 ) one autologous stem cell transplant ( ASCT ) ; 4 . Sixty day ( D +60 ) ASCT : RANDOMIZATION two arm maintenance : Arm A ( oral dexamethasone alone 40 mg/d 4 day every 28 day ) Arm B ( dexamethasone plus thalidomide 200 mg daily mouth ) 12 month disease progression .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>symptomatic multiple myeloma accordance International Myeloma Working Group criteria ; age 1870 year ; Performance status 02 Eastern Cooperative Oncology Group ( ECOG ) criteria ; normal hepatic function , define serum bilirubin &lt; 3 mg/dl alanine aminotransferase ( ALT ) asparagin aminotransferase ( AST ) &lt; 4x normal . evidence disease progression ASCT ; cardiac dysfunction ( systolic ejection fraction &lt; 50 % ) ; chronic respiratory disease ( carbon monoxide diffusion &lt; 50 % normal ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Treatment</keyword>
	<keyword>Maintenance</keyword>
	<keyword>Thalidomide</keyword>
</DOC>